The committee determined that an examination of the rare phenomenon was required, but in light of the fact that millions received the vaccine and nothing happened to them, it was decided not to recommend stopping the use.
Astra-Zenka vaccines
Photo:
Reuters
The EU Committee of Experts announced today (Wednesday) that blood clots formed in people who have received the "Astra-Zenika" vaccine can be treated as a "very rare side effect" of the vaccine, although a comprehensive examination is needed.
In doing so, it was in fact determined that there may be a causality between the blood clots, some of which were fatal, and the receipt of the vaccine.
As you may recall, only seven deaths were reported in the UK recently after receiving the vaccine, although this is a very small percentage of all vaccinators.
The European Medicines Agency stressed that in light of the fact that tens of millions have already received the vaccine and nothing has happened to them, they do not recommend stopping the use of the vaccine and leave the decision on the issue to each and every country.
"Our safety committee believes that the benefits of the vaccine in preventing Covid-19 morbidity outweigh the risks of side effects," the agency director said.
At the same time, the British body of experts entrusted with the approval of medicines in the kingdom also published its conclusions regarding blood clots, saying that it too had identified a possible link between the vaccine and blood clots.
In light of this, the British Special Committee on Vaccines has announced that it is preferable for people under the age of 30 not to receive this vaccine if there are alternative vaccines that can be offered to them.
In doing so, the UK joins a number of European countries that have restricted the vaccine in terms of age.